Thermo Fisher Scientific (TMO) Financials
Thermo Fisher Scientific (TMO) Historical Financial Statements and Key Metrics for 1994 - 2025
Full Thermo Fisher Scientific financials for 1994 - 2025 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Thermo Fisher Scientific Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2025-Jun-28 | 10,855 | 4,048 (37.3 %) | 1,917 (17.7 %) | 1,617 (14.9 %) | 2,798 | 4.28 |
| 2025-Mar-29 | 10,364 | 4,235 (40.9 %) | 1,716 (16.6 %) | 1,507 (14.5 %) | 1,716 | 3.98 |
| 2024-Dec-31 | 11,395 | 4,903 (43.0 %) | 2,016 (17.7 %) | 1,830 (16.1 %) | 3,000 | 4.78 |
| 2024-Sep-28 | 10,598 | 4,328 (40.8 %) | 1,838 (17.3 %) | 1,630 (15.4 %) | 2,906 | 4.24 |
| 2024-Jun-29 | 10,541 | 4,344 (41.2 %) | 1,758 (16.7 %) | 1,548 (14.7 %) | 2,548 | 4.04 |
| 2024-Mar-30 | 10,345 | 4,217 (40.8 %) | 1,720 (16.6 %) | 1,328 (12.8 %) | 2,556 | 3.46 |
| 2023-Dec-31 | 10,886 | 4,496 (41.3 %) | 1,854 (17.0 %) | 1,630 (15.0 %) | 1,854 | 4.20 |
Full historical income statements for 1994 - 2025 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2025-Jun-28 | 101,230 | 50,628 | 35,229 | 50,511 | 6,390 |
| 2025-Mar-29 | 99,041 | 49,555 | 34,189 | 49,357 | 5,947 |
| 2024-Dec-31 | 97,321 | 47,650 | 31,275 | 49,551 | 5,570 |
| 2024-Sep-28 | 100,364 | 51,265 | 35,313 | 48,992 | 6,645 |
| 2024-Jun-29 | 98,496 | 50,963 | 35,405 | 47,432 | 8,834 |
| 2024-Mar-30 | 97,095 | 51,472 | 35,608 | 45,516 | 7,257 |
| 2023-Dec-31 | 98,726 | 51,884 | 34,917 | 46,724 | 8,077 |
Full historical balance sheet data for 1994 - 2025 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2025-Jun-28 | 1,399 | -288 | -991 | 1,105 |
| 2025-Mar-29 | 723 | -527 | -102 | 361 |
| 2024-Dec-31 | 3,290 | 20 | -3,666 | 2,810 |
| 2024-Sep-28 | 2,166 | -3,578 | -1,190 | 1,894 |
| 2024-Jun-29 | 1,960 | -253 | -114 | 1,659 |
| 2024-Mar-30 | 1,251 | -2,030 | -1,821 | 904 |
| 2023-Dec-31 | 3,723 | -376 | -1,428 | 3,318 |
Full historical cash flow data for 1994 - 2025 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2025-Jun-28 | 154,330 | 184,983 | 14.22 | 23.86 | 3.06 |
| 2025-Mar-29 | 189,060 | 219,115 | 18.24 | 31.36 | 3.83 |
| 2024-Dec-31 | 199,168 | 226,434 | 17.48 | 27.21 | 4.02 |
| 2024-Sep-28 | 234,708 | 265,376 | 22.15 | 36.00 | 4.79 |
| 2024-Jun-29 | 211,246 | 239,567 | 20.04 | 34.12 | 4.45 |
| 2024-Mar-30 | 222,022 | 252,124 | 21.46 | 41.80 | 4.88 |
| 2023-Dec-31 | 205,416 | 232,256 | 18.87 | 31.51 | 4.40 |
Full historical valuation and operating metrics for 1994 - 2025 are included in the
US Historical Financials dataset.